Myriant Corp. recently announced the successful scaling and commercial production of bio-succinic acid at ThyssenKrupp Uhde’s biotech commercial validation facility in Leuna, Germany. The production process reportedly meets targets for commercial yield and product quality.
Myriant and ThyssenKrupp Uhde signed an exclusive alliance agreement in 2009 to commercialize bio-succinic acid, with several goals: to keep the bio-succinic acid process cost competitive; to produce the highest purity product at commercial scale; and to enable ThyssenKrupp Uhde to provide process and performance guarantees for the bio-succinic acid process at future Myriant plants built by Uhde.
“With the success at Leuna, we have achieved the first objective set out in our alliance agreement with ThyssenKrupp Uhde,” said Cenan Ozmeral, Ph.D., COO of Myriant. “Producing on-spec, commercial-grade bio-succinic acid while meeting our commercial cost targets would not be possible without the expert engineering, design and process expertise of ThyssenKrupp Uhde, our global alliance partner and our selected engineering partner for future commercial production plants.
For additional information, visit www.myriant.com.
Report Abusive Comment